-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Evofem Biosciences, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2019 to Q2 2024.
- Evofem Biosciences, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $2.24M, a 2.09% increase year-over-year.
- Evofem Biosciences, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $10.2M, a 59.2% decline year-over-year.
- Evofem Biosciences, Inc. annual Selling and Marketing Expense for 2023 was $11.7M, a 73.5% decline from 2022.
- Evofem Biosciences, Inc. annual Selling and Marketing Expense for 2022 was $44M, a 61.2% decline from 2021.
- Evofem Biosciences, Inc. annual Selling and Marketing Expense for 2021 was $113M, a 100% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)